Detalhe da pesquisa
1.
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Hematol Oncol
; 41(1): 50-60, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36251440
2.
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
Cell Biol Toxicol
; 39(3): 795-811, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34519926
3.
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment.
Hematol Oncol
; 40(4): 734-742, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35618655
4.
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia.
BMC Cancer
; 18(1): 1117, 2018 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30442119
5.
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
Hematol Oncol
; 39(4): 580-583, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33963566
6.
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells.
Front Immunol
; 15: 1386517, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38812504
7.
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.
Blood Adv
; 6(6): 1742-1753, 2022 03 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34649276
8.
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia.
Front Oncol
; 11: 728613, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34660293
9.
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia.
Front Oncol
; 11: 684396, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34150648
10.
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.
Cancers (Basel)
; 11(11)2019 Oct 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31717700
11.
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia.
J Oncol
; 2019: 5985923, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31827512
12.
Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia.
Cancers (Basel)
; 11(12)2019 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31817495
13.
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia.
J Hematol Oncol
; 11(1): 99, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30068368
14.
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia.
Oncotarget
; 7(33): 53377-53391, 2016 Aug 16.
Artigo
Inglês
| MEDLINE | ID: mdl-27438145